MQP

FOR JERRY #1 OF 3, IOVA

Long
MQP Premium Updated   
NASDAQ:IOVA   Iovance Biotherapeutics, Inc
This is 12-month outlook for IOVA from several different angles (meaning sized bars, heavy emphasis on 1-day and 2-day). Temporary weakness in volume structure has been considered and expected to resolve by January 2021. Future looks bright .
Comment:
Here is a zoom in for temporary weakness expected this late Nov 2020 to Jan 2021 window: